Passage BIO PASG Cash Flow Statement (2019-2026)

NASDAQ PASG
$3.59 -0.01 (-0.28%)
At close: Oct 21, 2026 · 4:00 PM EDT
Reported Financials

Passage BIO Quarterly Cash Flow Statement

Periods 30 quarters
Latest Jun 2026

Passage BIO reported cash from operations of -$9.18M and free cash flow of -$9.18M for the quarter ended Jun 2026, down 45.0% year over year. This cash flow statement covers 30 quarters of results from Mar 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income
-46.92M-51.15M-42.81M-39.54M-26.70M-27.07M-34.34M-23.86M-27.11M-16.76M-16.71M-15.99M-19.34M-12.73M-15.41M-9.40M-7.75M-12.98M-7.60M-7.82M
Depreciation, Depletion & Amortization
Amortization of Deferred ChargesAmort. Deferred Charges
0.89M0.54M0.88M0.28M0.06M-0.43M-0.10M-0.77M-0.32M-0.85M-0.44M-0.30M-0.42M-0.37M0.13M
Depreciation & Amortization (CF)Dep. & Amort.
0.46M0.67M0.90M0.90M0.90M0.97M1.00M1.00M1.00M0.81M0.81M0.80M0.80M0.70M0.20M0.20M0.20M0.13M0.13M0.07M
Share-based CompensationStock Comp.
6.82M7.58M6.34M6.28M2.86M3.48M2.78M3.74M2.82M1.57M1.60M1.58M1.40M1.25M0.86M0.92M0.61M0.61M0.56M0.53M
Gains from Sales and DivestituresGains Divest
-0.50M
Gains from Investment SecuritiesGains Investment
0.01M-0.45M-0.92M-0.24M0.11M0.50M0.54M0.09M0.15M0.15M-0.03M0.00M0.10M-0.02M-0.01M
Asset Writedowns and ImpairmentWritedown
5.39M0.44M4.80M2.64M3.51M
Other non-cash itemsOther Non-Cash
5.50M1.00M1.50M1.50M-0.63M-1.94M
Change in Working Capital
Change in Account PayablesChange Payables
-7.79M0.12M-0.96M-0.28M-3.74M-0.43M-1.04M0.36M-0.63M-1.47M0.39M-1.07M0.87M-0.75M0.72M0.94M0.07M0.16M0.20M-0.41M
Change in Accured ExpensesChange Accured Exp.
0.06M6.74M-4.82M1.11M-1.34M-2.28M1.87M0.28M0.55M-2.04M-4.19M0.58M-1.33M-0.02M-2.71M0.08M-0.07M0.65M-0.76M-0.33M
Change in Other Operating AssetsOther Assets Change
0.53M-3.28M6.13M-5.08M-3.06M-1.79M-7.42M-1.70M0.79M0.73M0.33M-0.89M-0.89M-0.33M0.68M-0.04M0.27M-1.52M-0.05M-0.63M
Change in Other Operating LiabilitiesOther Liabilities Change
0.46M0.46M3.23M0.51M1.01M2.50M
Other Working Capital ChangesOther WC Changes
-0.07M3.73M-0.42M-0.08M0.02M0.02M0.02M0.04M0.04M0.04M0.05M0.06M0.06M0.11M0.10M0.12M0.12M0.13M4.97M2.36M
Cash from OperationsCash from Ops.
-41.06M-30.78M-44.71M-26.08M-23.40M-24.02M-22.45M-17.14M-19.16M-19.52M-18.93M-13.14M-7.45M-8.44M-13.85M-6.33M-4.85M-6.48M-12.99M-9.18M
Investing Activities
Capital ExpendituresCapex
6.01M6.82M0.73M0.83M0.24M0.47M0.03M0.10M0.00M0.01M0.01M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.59M0.59M0.02M
Change in Property, Plant and EquipmentChange in PP&E
-6.01M-6.82M-0.73M-0.83M-0.24M-0.47M-0.03M-0.10M0.00M-0.01M-0.01M0.59M0.59M0.02M
Change in IntangiblesChange Intangibless
5.50M0.50M1.50M1.50M
Purchase of InvestmentsInvestments Purchased
37.71M32.69M37.40M21.47M57.43M41.53M51.40M22.13M28.11M27.79M13.81M37.02M21.77M15.58M
Sale and Maturity of InvestmentsInvestments Sold
37.67M36.40M56.94M38.31M54.41M38.65M72.64M36.20M50.57M35.41M39.06M38.06M36.76M29.27M39.05M
Cash from Investing ActivitiesCash from Investing
-11.56M-3.61M17.31M16.00M-4.76M-3.36M21.22M13.97M22.45M7.60M25.25M1.05M14.97M13.68M39.63M0.59M0.02M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
0.04M0.46M0.05M0.24M0.08M0.06M0.05M0.05M0.01M
Net Shares Issued and RepurchasedNet Shares Issued
0.04M0.46M0.05M0.24M0.08M0.06M0.05M0.05M0.01M
Net Preferred Shares Issued and RepurchasedNet Pref. Shares Issued
8.74M
Net Equity Issued and RepurchasedNet Equity Issued
0.04M0.46M0.05M0.24M0.08M0.06M0.05M8.74M0.05M0.01M
Other financing activitiesOther financing
Cash from Financing ActivitiesCash from Financing
0.04M0.46M0.05M-0.41M-0.41M-0.59M0.05M8.74M0.09M0.05M0.01M
Additional items
Change in Cash
-52.57M-33.93M-27.35M-10.49M-28.56M-27.97M-1.23M-3.08M3.29M-11.87M15.06M-12.00M7.52M5.28M25.78M-5.73M-4.85M-6.47M-12.97M-9.18M
Ending Cash Balance
162.89M128.97M101.61M91.13M62.57M34.60M33.37M30.29M33.58M21.71M36.77M24.77M32.29M37.57M63.36M57.63M52.77M46.30M33.34M24.16M
Free Cash FlowFCF
-47.07M-37.59M-45.44M-26.91M-23.64M-24.50M-22.47M-17.24M-19.17M-19.53M-18.93M-13.14M-7.45M-8.46M-13.85M-6.33M-4.85M-6.48M-12.99M-9.18M
Net Cash FlowNCF
-52.57M-33.93M-27.35M-10.49M-28.56M-27.97M-1.23M-3.17M3.29M-11.87M15.06M-12.00M7.52M5.28M25.78M-5.75M-4.85M-6.47M-12.97M-9.18M

Passage BIO Cash Flow Statement API

Pull Passage BIO's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=PASG&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY